Welcome to the website of the Department of Emergency Medicine at the University of Maryland School of Medicine.
Our urban location provides a fast-paced and challenging environment for learning and clinical practice. Coupled with state-of-the art technology and cutting-edge academic resources available to us as part of the University of Maryland School of Medicine, we offer comprehensive training in emergency medicine. Our educational responsibilities have our highest commitment. We are shaping the future of emergency medicine in the United States and abroad.
Jon Mark Hirshon, MD, MPH, FACEP, FAAEM, FACPM, Professor, Department of Emergency Medicine, was among the authors of "Driving Behavior and Road Traffic Crashes Among Professional and Nonprofessional Drivers in South Egypt” (abstract available), which was published in the International Journal of Injury Control and Safety Promotion on July 8. (continued)
Jon Mark Hirshon, MD, MPH, FACEP, FAAEM, FACPM, Professor, and Laura Pimentel, MD, CPME, Clinical Professor, both from the Department of Emergency Medicine, were among the authors of the article, “Resource Utilization in Non-Academic Emergency Departments With Advanced Practice Providers” (full text available), which was published in the Western Journal of Emergency Medicine in July. (continued)
Mike Witting, MD, Professor; Mak Moayedi, MD, CDEM, Assistant Professor; Jon Mark Hirshon, MD, MPH, FACEP, FAAEM, FACPM, Professor; and Steve Schenkel, MD, Associate Professor, all from the Department of Emergency Medicine, were among the authors of “Predicting Failure of Intravenous Access in Adults: The Value of Prior Difficulty” (full text available), which was published in the Journal of Emergency Medicine in July. (continued)
Slipped Capital Femoral Epiphysis (SCFE) Progressive, posterior medial displacement (slipping) of the proximal femoral epiphysis Complicated... (continued)
Pearl: consider desmopressin (DDAVP) for patients with an intracranial hemorrhage who are taking an antiplatelet. Caution, this is not for patients with... (continued)
Adenosine is an atrioventricular nodal blocking agent that is commonly used in the treatment of supraventricular tachycardia. It is dosed as 6... (continued)
After many years of national shortage and FDA’s black box warning in 2001 (QT prolongation) droperidol is slowing becoming available.... (continued)
Interventions Shown to Reduce Mortality in RCTs Santacruz and colleagues recently performed a systematic review to determine which multicenter... (continued)